— Know what they know.
Not Investment Advice
Also trades as: ALTHE.PA (PAR) · $vol 0M

TCLIF OTC

Theraclion S.A.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +312841.2% 1Y: +312841.2% 3Y: -76.7% 5Y: -72.6%
$0.53
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Devices · Tech Score Neutral · Power 51 · $38.9M mcap · 52M float · 0.0002% daily turnover

Balance Sheet Trends

Total Assets
$11M -38.6% ▼
5Y CAGR: +1.8%
Total Liabilities
$11M -11.9% ▼
5Y CAGR: +1.6%
Shareholders Equity
-$114 -100.0% ▼
Cash & Investments
$4M -46.6% ▼
5Y CAGR: +24.4%
Total Debt
$1M -33.6% ▼
5Y CAGR: +25.0%
Net Debt
-$3M +51.0% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$2M$2M$2M$8M$4M
Short-Term Investments$31K$31K$31K$0$0
Cash & ST Investments$2M$2M$3M$8M$4M
Net Receivables$1M$1M$2M$4M$447K
Inventory$2M$3M$3M$3M$2M
Other Current Assets$1M$1M$1M$1M$1M
Total Current Assets$7M$8M$9M$16M$8M
Property, Plant & Equip.$62K$45K$178K$106K$882K
Goodwill & Intangibles$948K$958K$963K$1M$1M
Long-Term Investments$1M$3M$3M$1M$1M
Other Non-Current Assets$75K$120K$669K$201K$156K
Total Non-Current Assets$4M$4M$5M$3M$3M
Total Assets$11M$12M$14M$19M$11M
— Liabilities —
Accounts Payable$1M$975K$2M$2M$1M
Short-Term Debt$72$0$0$0$0
Deferred Revenue$1M$0$0$0$0
Other Current Liabilities$266K$2M$2M$5M$2M
Total Current Liabilities$3M$3M$4M$7M$4M
Long-Term Debt$4M$2M$9M$2M$1M
Other Non-Current Liab.$88K$7M$0$7M$6M
Total Non-Current Liabilities$11M$9M$9M$8M$8M
Total Liabilities$14M$13M$13M$13M$11M
— Equity —
Common Stock$809K$1M$1M$2M$2M
Retained Earnings-$4M-$4M-$5M-$4M-$6M
Accumulated OCI$0$0$0-$5K$0
Total Stockholders Equity-$3M-$1M$545K$6M-$114
Total Liabilities & Equity$11M$12M$14M$19M$11M
— Key Metrics —
Total Debt$11M$2M$3M$2M$1M
Net Debt$2M-$99K$21K-$6M-$3M
Total Investments$1M$3M$3M$1M$1M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms